Petco Health & Wellness Company, Inc.
Close on Oct 19, 2026
- Market cap
- $679.76M
- P/E (TTM)
- 23.4
- Dividend yield
- –
Earnings
Next report expected Nov 24, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Aug 1, 2026 | Sep 2, 2026 | During market hours | $1.50B | $0.13 | – |
| Q1 FY2026 Ended May 2, 2026 | Jun 3, 2026 | During market hours | $1.50B | $-0.05 | – |
| Q4 FY2025 Ended Jan 31, 2026 | Mar 11, 2026 | During market hours | $1.52B | $-0.01 | – |
| Q3 FY2025 Ended Nov 1, 2025 | Nov 25, 2025 | During market hours | $1.50B | $0.03 | – |
| Q2 FY2025 Ended Aug 2, 2025 | Aug 28, 2025 | During market hours | $1.50B | $0.05 | – |
| Q1 FY2025 Ended May 3, 2025 | Jun 5, 2025 | During market hours | $1.49B | $-0.04 | – |
| Q4 FY2024 Ended Feb 1, 2025 | Mar 26, 2025 | During market hours | $1.55B | $-0.05 | – |
| Q3 FY2024 Ended Nov 2, 2024 | Dec 5, 2024 | During market hours | $1.51B | $-0.06 | $-0.02 |
| Q2 FY2024 Ended Aug 3, 2024 | Sep 10, 2024 | During market hours | $1.52B | $-0.09 | $-0.02 |
| Q1 FY2024 Ended May 4, 2024 | May 22, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Feb 3, 2024 | Mar 13, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Sep 2, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Capital Expenditures | FY 2026 | $140.00M | Maintained |
| Adjusted EBITDAnon-GAAP | Q3 2026 | $100.00M to $103.00M | New |
| Adjusted EBITDAnon-GAAP | FY 2026 | $415.00M to $430.00M | Maintained |
| Depreciation & Amortization | FY 2026 | $200.00M | Raised |
| Net Interest Expense | FY 2026 | $122.00M | Lowered |
| Net Store Closures | FY 2026 | 15 to 20 | Maintained |
| Net Sales | Q3 2026 | 0.4% to 1% growth | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Petco Health & Wellness filed with the SEC
Petco Reports Second Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Appoints Jeffrey Naylor to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Reports First Quarter 2026 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Reports Fourth Quarter and Full Year 2025 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Announces Completion of Refinancing and Glenn Murphy’s Transition to Chairman
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Announces Pricing of its $600,000,000 Offering of Senior Secured Notes
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Announces $650,000,000 Offering of Senior Secured Notes
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Announces Launch of Debt Refinancing Transaction; Reaffirms
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Reports Third Quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Reports Second Quarter 2025 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco to Present at Goldman Sachs Global Retailing Conference on Sept. 4, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports First Quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Third Quarter 2024 Earnings Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Second Quarter 2024 Earnings Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Names Joel D. Anderson as
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Announces Evolution of Leadership Team
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports First Quarter 2024 Earnings Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Announces Appointment of Glenn Murphy
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2023 Earnings
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
R. Michael Mohan, Previously Lead Independent Director, Appointed Interim CEO
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Petco to Participate in the UBS Global Consumer and Retail Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Third Quarter Earnings
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco to Participate in the Evercore ISI Virtual Pet Care Summit
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco to Participate in the 30th Annual Goldman Sachs Global Retailing Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports First Quarter Earnings and Reaffirms Full Year 2023 Guidance
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2022 Earnings, Issues 2023 Outlook
Acquisition or disposition completed · Regulation FD disclosure · EX-99 to Form 8-K
Petco to Participate in the 25 th Annual Needham Growth Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Updates Time for Participation in Morgan Stanley Global Consumer & Retail Conference
Regulation FD disclosure · EX-99.1 to Form 8-K/A
Petco to Participate in the Morgan Stanley Global Consumer & Retail Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Third Quarter Earnings
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco to Present at Goldman Sachs 29 th Annual Global Retailing Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports First Quarter Earnings
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K/A
Petco Health + Wellness Company, Inc. Reports First Quarter Earnings
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Announces Long-Term
Regulation FD disclosure · EX-99.1 to Form 8-K
Petco Health + Wellness Company, Inc. Reports Record Year of Revenue and Profitability, Issues 2022 Guidance
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Petco to Present at BofA Securities 2022 Consumer and Retail Technology Conference
Regulation FD disclosure · EX-99.1 to Form 8-K